key: cord-0719747-kzp8ud7i
authors: Delanghe, Joris R.; De Buyzere, Marc L.; De Bruyne, Sander; Van Criekinge, Wim; Speeckaert, Marijn M.
title: The potential influence of human Y-chromosome haplogroup on COVID-19 prevalence and mortality
date: 2020-08-22
journal: Ann Oncol
DOI: 10.1016/j.annonc.2020.08.2096
sha: c97cfad189886ca52b9d96e934c1d72da76c1d33
doc_id: 719747
cord_uid: kzp8ud7i

nan

With interest, we read the paper of Montopoli et al. about the association between androgendepletion therapies (ADT) in prostate cancer patients and protection against coronavirus disease 2019 (COVID-19). The TMPRSS2 regulated expression by the androgen receptor (AR) in non-prostatic tissues might explain the increased susceptibility of men to develop severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections. ADT, based on LHRH agonist/antagonists or AR inhibitors, might reduce SARS-CoV-2 infections or complications in high-risk male populations [1] . The outbreak of the pandemic shows a marked geographical variation in the prevalence and mortality of COVID-19. Some Western European regions (e.g. Bergamo in Italy, Noord-Brabant in the Netherlands, Limburg in Belgium) were severely affected. As a potentially protective role of the double Xchromosome in females was suggested [2] , we postulated that Y chromosome polymorphisms might also partly explain the variable prevalence and mortality.

The phylogenetic resolution of the Y-chromosome haplogroup (YHG) tree is now sufficiently high to be able to detect geographic patterns on a micro-regional scale [3, 4] . A critical role for genetic variation in chromosome Y in regulating susceptibility to influenza A virus infection and in augmenting pathogenic immune responses in the lung has been demonstrated in a murine model [5] . We have compared the prevalence of Y chromosome haplotypes in the Netherlands and Dutch-speaking Belgium (Flanders) with the prevalence and mortality of COVID-19, using individualized data of 12 Dutch and 5 Flemish provinces. with the R1b-S116 haplotype frequency (r² = 0.601 and 0.453, respectively). Similarly, in European countries, a marked correlation was noted: COVID-19 prevalence (Fig. 1B) and mortality showed a strong correlation with the R1b-S116 haplotype frequency (r² = 0.390 and 0.493, respectively). Even in separate multivariate regression models for COVID-19 prevalence and mortality frequency including the listed candidate markers, R1b-S116 remained a significant factor (next to ACE1 polymorphism for COVID-19 prevalence).

Remarkably, among Italians, the heavily affected Bergamo area is characterized by a very high R1b-S116 haplotype frequency (0.179). Among European countries, a linear positive correlation was found between R1b-S116 allele frequency and basic reproduction numbers 

Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (n=4532)

COVID-19 and Individual Genetic Susceptibility/Receptivity: Role of ACE1/ACE2 Genes, Immunity, Inflammation and Coagulation. Might the Double X-Chromosome in Females Be Protective against SARS-CoV-2 Compared to the Single X-Chromosome in Males?

The Dutch Y-chromosomal landscape

A major Y-chromosome haplogroup R1b Holocene era founder effect in Central and Western Europe

Genetic variation in chromosome Y regulates susceptibility to influenza A virus infection